As the U.S. Food and Drug Administration (FDA) seeks to modernise its regulatory processes,...
Balancing Enforcement and Innovation: CTP’s Post-RIF Strategy in Focus
As the U.S. Food and Drug Administration’s Center for Tobacco Products (CTP) adjusts to a new era of leadership and reduced staffing, a clearer regulatory direction is beginning to emerge. Following months of internal restructuring and uncertainty,...
Results - 100 Blogs
Since January 2025, the regulatory landscape for tobacco and nicotine products in the United States...
When developing a nicotine product, the choice between freebase nicotine and nicotine salts plays a...
Chromatography is a cornerstone of analytical testing for nicotine products. It allows us to...
Our Chief Commercial Officer, Andy Mooney, recently attended the Global Forum on Nicotine (GFN)...
The Next Generation Nicotine Delivery (NGND) conference in Miami delivered an energetic and...
Introduction: Preparing for Regulatory Change in the Vape Industry
The inaugural ATNF conference, held from 15–17 April 2025, brought together stakeholders across the...
As global economic dynamics shift, the reduced-risk nicotine industry, already contending with...
If you have a specific question for one of our scientific or regulatory experts, get in touch with a member of our team today.
